Dale A. Stringfellow

903 total citations
24 papers, 705 citations indexed

About

Dale A. Stringfellow is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Dale A. Stringfellow has authored 24 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Dale A. Stringfellow's work include Synthesis and biological activity (7 papers), Quinazolinone synthesis and applications (7 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Dale A. Stringfellow is often cited by papers focused on Synthesis and biological activity (7 papers), Quinazolinone synthesis and applications (7 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Dale A. Stringfellow collaborates with scholars based in United States and Japan. Dale A. Stringfellow's co-authors include F.A. Fitzpatrick, Harold E. Renis, Sheldon D. Weed, Lowell A. Glasgow, James B. Gloer, J. Patrick McGovren, Kenneth L. Rinehart, Sandra L. Kuentzel, Li H. Li and Byron H. Long and has published in prestigious journals such as Nature, Science and JNCI Journal of the National Cancer Institute.

In The Last Decade

Dale A. Stringfellow

23 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dale A. Stringfellow United States 13 255 198 179 136 110 24 705
Paula E. Scarborough United States 11 315 1.2× 69 0.3× 112 0.6× 86 0.6× 99 0.9× 15 877
Frederick Cohen United States 18 384 1.5× 373 1.9× 61 0.3× 72 0.5× 71 0.6× 31 810
Mark Ammirati United States 14 598 2.3× 173 0.9× 77 0.4× 121 0.9× 169 1.5× 20 1.2k
Tsutomu Agatsuma Japan 16 767 3.0× 217 1.1× 272 1.5× 147 1.1× 90 0.8× 22 1.1k
T. Ogawa Japan 15 410 1.6× 228 1.2× 214 1.2× 118 0.9× 71 0.6× 34 795
John E. Toth United States 14 464 1.8× 245 1.2× 86 0.5× 41 0.3× 185 1.7× 30 793
Kouhei Matsui Japan 18 632 2.5× 265 1.3× 170 0.9× 656 4.8× 190 1.7× 26 1.5k
R. B. Lingham United States 8 303 1.2× 81 0.4× 94 0.5× 35 0.3× 95 0.9× 10 469
Keiji Hemmi Japan 12 299 1.2× 249 1.3× 63 0.4× 55 0.4× 82 0.7× 32 572
Henry W. Dion United States 14 388 1.5× 199 1.0× 157 0.9× 24 0.2× 47 0.4× 20 632

Countries citing papers authored by Dale A. Stringfellow

Since Specialization
Citations

This map shows the geographic impact of Dale A. Stringfellow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale A. Stringfellow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale A. Stringfellow more than expected).

Fields of papers citing papers by Dale A. Stringfellow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale A. Stringfellow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale A. Stringfellow. The network helps show where Dale A. Stringfellow may publish in the future.

Co-authorship network of co-authors of Dale A. Stringfellow

This figure shows the co-authorship network connecting the top 25 collaborators of Dale A. Stringfellow. A scholar is included among the top collaborators of Dale A. Stringfellow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale A. Stringfellow. Dale A. Stringfellow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schurig, John E., William C. Rose, Hideo Kamei, et al.. (1990). Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent. Investigational New Drugs. 8(1). 7–15. 12 indexed citations
2.
Long, Byron H. & Dale A. Stringfellow. (1988). Inhibitors of topoisomerase II: Structure-activity relationships and mechanism of action of podophyllin congeners. Advances in Enzyme Regulation. 27. 211–214. 41 indexed citations
3.
Stringfellow, Dale A. & John E. Schurig. (1987). The search for more active and less toxic mitomycin and etoposide analogs. Cancer Treatment Reviews. 14(3-4). 291–295. 6 indexed citations
4.
Stringfellow, Dale A.. (1986). Clinical application of interferons and their inducers. 8 indexed citations
5.
Stringfellow, Dale A.. (1986). [93] Measurement of hyporesponsiveness to interferon and interferon induction with prostaglandins. Methods in enzymology on CD-ROM/Methods in enzymology. 119. 707–712. 1 indexed citations
6.
Skulnick, Harvey I., et al.. (1985). Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents. Journal of Medicinal Chemistry. 28(12). 1864–1869. 41 indexed citations
7.
Chang, Alex Y., et al.. (1983). Treatment of 7,12-Dimethylbenz (α) Anthracene (DMBA)-Induced Rat Mammary Cancer by 2-Amino-5-Bromo-6-Phenyl-4-(3H)Pyrimidinone (ABPP) ± Tamoxifen. Journal of Interferon Research. 3(3). 299–304. 3 indexed citations
8.
Brideau, Roger J. & Dale A. Stringfellow. (1983). Antiproliferative Action of Interferon on Murine LI210 Cells: Interrelationship with Prostaglandins. Journal of Interferon Research. 3(4). 409–415. 1 indexed citations
9.
Weed, Sheldon D. & Dale A. Stringfellow. (1983). Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice. Antiviral Research. 3(4). 269–274. 15 indexed citations
10.
Fitzpatrick, F.A. & Dale A. Stringfellow. (1983). Influence of thromboxane synthetase inhibitors on virus replication in human lung fibroblasts in vitro. Biochemical and Biophysical Research Communications. 116(1). 264–271. 3 indexed citations
11.
Milas, Luka, Evan M. Hersh, Dale A. Stringfellow, & Nancy Hunter. (1982). Studies on the Antitumor Activities of Pyrimidinone-Interferon Inducers. I. Effect Against Artificial and Spontaneous Lung Metastases of Murine Tumors<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>. JNCI Journal of the National Cancer Institute. 68(1). 139–45. 17 indexed citations
12.
Stringfellow, Dale A.. (1981). [38] Induction of interferon with low molecular weight compounds: Fluorenone esters, ethers (tilorone), and pyrimidinones. Methods in enzymology on CD-ROM/Methods in enzymology. 78(Pt A). 262–284. 9 indexed citations
13.
Stringfellow, Dale A.. (1981). Antineoplastic properties of pyrimidinone interferon inducers. Advances in Enzyme Regulation. 19. 335–348. 11 indexed citations
14.
Stringfellow, Dale A., et al.. (1980). Interferon Induction by 5-Halo-6-Phenyl Pyrimidinones. Journal of Interferon Research. 1(1). 1–14. 29 indexed citations
15.
Wierenga, Wendell, et al.. (1980). 5-Substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral- and interferon-inducing agents. Journal of Medicinal Chemistry. 23(3). 237–239. 41 indexed citations
16.
Stringfellow, Dale A. & F.A. Fitzpatrick. (1979). Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells. Nature. 282(5734). 76–78. 91 indexed citations
17.
Stringfellow, Dale A.. (1978). Prostaglandin Restoration of the Interferon Response of Hyporeactive Animals. Science. 201(4353). 376–378. 38 indexed citations
18.
Stringfellow, Dale A. & Sheldon D. Weed. (1977). Feline Interferon Response to 2-Amino-5-Bromo-6-Methyl-4-Pyrimidinol (U-25,166). American Journal of Veterinary Research. 38(12). 1963–1967. 8 indexed citations
19.
20.
Stringfellow, Dale A. & Lowell A. Glasgow. (1972). Tilorone Hydrochloride: an Oral Interferon-Inducing Agent. Antimicrobial Agents and Chemotherapy. 2(2). 73–78. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula E. Scarborough Breakdown of academic impact, for papers by Frederick Cohen Breakdown of academic impact, for papers by Mark Ammirati Breakdown of academic impact, for papers by Tsutomu Agatsuma Breakdown of academic impact, for papers by T. Ogawa Breakdown of academic impact, for papers by John E. Toth Breakdown of academic impact, for papers by Kouhei Matsui Breakdown of academic impact, for papers by R. B. Lingham Breakdown of academic impact, for papers by Keiji Hemmi Breakdown of academic impact, for papers by Henry W. Dion
Rankless by CCL
2026